Enzymatic Wound Debridement Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The market is segmented by Type (Chronic Wounds, Acute Wounds), by Product, by End-User, and by Geography.

Market Snapshot

Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Enzymatic Wound Debridement market is projected to grow with a CAGR of nearly 5.3% over the forecast period. The major factor attributing to the growth of the market is the increase in the incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the major factors boosting growth.

According to International Diabetes Federation, roughly 463 million adults were living with diabetes in the year 2019, by 2045 this will rise to 700 million and around 374 million people are at increased risk of developing type 2 diabetes. The rising cases of diabetic people indicate the rising number of chronic wounds such as Diabetic Foot Ulcers, etc. which is augmenting the growth of the market studied. Furthermore, the growing investments in research and development programs by the government to develop the medical infrastructure in this section is boosting the market growth. However, the stringent regulatory policies is the major drawback of the market growth.

Scope of the Report

As per the scope of the report, debridement is the procedure in which infected tissue is removed from the wound until the healthy tissue is exposed. Enzymatic debridement is the process of using exogenous enzymes to the surface of the wound so the degradation of necrotic tissue can occur without any negative effects on viable, granulation tissue. This report is segmented by Type, by Product, by End-User, and by Geography.

By Type
Chronic Wounds
Acute Wounds
By Product
Collagenase Product
Papain Product
Others
By End-User
Hospitals
Homecare
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Collagenase-based Enzymatic Wound Debridement Products are Expected to Witness Rapid Growth

Collagenase-based enzymatic wound debridement products are predominantly used for healing surgical wounds. Most surgical wounds after cancer surgery are relatively large and deep, which generates exudate that needs regular supervision. Thus, the proper use of these products helps handle large wounds, which substantially reduce the risk of infection. Therefore, the rising incidence of chronic diseases is anticipated to increase the demand for enzymatic wound debridement products, thereby propelling market growth over the forecast period.

Furthermore, an increasing number of accidents, such as road accidents, burns, and trauma, across the world is also projected to propel growth. According to World Health Organization, 1.35 million people die every year as a result of road traffic crashes. Thus, rise in the number of accidents is expected to boost the growth of the segment.

Number_of_Accident_and_Emergency_cases_in_United_Kingdom,_by_year(Millions)

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, high prevalence of chronic diseases and accidents in the region, and established healthcare infrastructure. According to the American Association for the Surgery of Trauma, in 2017, around 1.2 million people died globally, accounting for deaths of around 3,242 people per day in road accidents every year. Furthermore, beneficial government initiatives and an increase in the number of research partnerships are some of the drivers expected to increase market growth.

Enzymatic Wound Debridement Market

Competitive Landscape

The Enzymatic Wound Debridement market is moderately competitive and consists of several major players. Some of the companies which are currently present in the market are B. Braun Melsungen AG, ConvaTec Inc., Smith & Nephew, Integra LifeSciences Corporation, Mölnlycke Health Care AB, Healthpoint, Ltd, MediWound.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Chronic Wounds

      2. 4.2.2 Increasing Number of Accidents

      3. 4.2.3 Increasing Technologically Advanced Products

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent regulatory policies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type

      1. 5.1.1 Chronic Wounds

      2. 5.1.2 Acute Wounds

    2. 5.2 By Product

      1. 5.2.1 Collagenase Product

      2. 5.2.2 Papain Product

      3. 5.2.3 Others

    3. 5.3 By End-User

      1. 5.3.1 Hospitals

      2. 5.3.2 Homecare

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 B. Braun Melsungen AG

      2. 6.1.2 ConvaTec Inc.

      3. 6.1.3 Smith & Nephew

      4. 6.1.4 Integra LifeSciences Corporation

      5. 6.1.5 Molnlycke Health Care AB

      6. 6.1.6 Healthpoint, Ltd

      7. 6.1.7 MediWound

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Enzymatic Wound Debridement Market market is studied from 2018 - 2026.

The Enzymatic Wound Debridement Market is growing at a CAGR of 5.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

B. Braun Melsungen AG, ConvaTec Inc., Smith & Nephew, Integra LifeSciences Corporation, Mölnlycke Health Care AB are the major companies operating in Enzymatic Wound Debridement Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!